Next-generation cancer organoids
Organotypic models of patient-specific tumours are revolutionizing our understanding of
cancer heterogeneity and its implications for personalized medicine. These advancements …
cancer heterogeneity and its implications for personalized medicine. These advancements …
Next-generation cancer organoids.
BL LeSavage, RA Suhar, N Broguiere, MP Lutolf… - Nature …, 2021 - europepmc.org
Organotypic models of patient-specific tumours are revolutionizing our understanding of
cancer heterogeneity and its implications for personalized medicine. These advancements …
cancer heterogeneity and its implications for personalized medicine. These advancements …
Next-generation cancer organoids
BL LeSavage, RA Suhar, N Broguiere… - Nature …, 2022 - ui.adsabs.harvard.edu
Organotypic models of patient-specific tumours are revolutionizing our understanding of
cancer heterogeneity and its implications for personalized medicine. These advancements …
cancer heterogeneity and its implications for personalized medicine. These advancements …
Engineered extracellular matrices reveal stiffness-mediated chemoresistance in patient-derived pancreatic cancer organoids
BL LeSavage, AE Gilchrist, BA Krajina, K Karlsson… - bioRxiv, 2022 - biorxiv.org
Pancreatic ductal adenocarcinoma (PDAC) is characterized by its fibrotic and stiff
extracellular matrix (ECM); however, the role that altered cell-ECM signaling may play in …
extracellular matrix (ECM); however, the role that altered cell-ECM signaling may play in …
[PDF][PDF] Next-generation cancer organoids
BL LeSavage, RA Suhar, N Broguiere, MP Lutolf… - stanford.edu
Organotypic models of patient-specific tumours are revolutionizing our understanding of
cancer heterogeneity and its implications for personalized medicine. These advancements …
cancer heterogeneity and its implications for personalized medicine. These advancements …
[PDF][PDF] Next-generation cancer organoids
BL LeSavage, RA Suhar, N Broguiere, MP Lutolf… - Nature Materials, 2021 - par.nsf.gov
Organotypic models of patient-specific tumours are revolutionizing our understanding of
cancer heterogeneity and its implications for personalized medicine. These advancements …
cancer heterogeneity and its implications for personalized medicine. These advancements …
Next-generation cancer organoids
BL LeSavage, RA Suhar, N Broguiere… - Nature …, 2022 - pubmed.ncbi.nlm.nih.gov
Organotypic models of patient-specific tumours are revolutionizing our understanding of
cancer heterogeneity and its implications for personalized medicine. These advancements …
cancer heterogeneity and its implications for personalized medicine. These advancements …
Next-generation cancer organoids
BL LeSavage, RA Suhar, N Broguiere… - Nature …, 2022 - infoscience.epfl.ch
Organotypic models of patient-specific tumours are revolutionizing our understanding of
cancer heterogeneity and its implications for personalized medicine. These advancements …
cancer heterogeneity and its implications for personalized medicine. These advancements …
[PDF][PDF] Next-generation cancer organoids
BL LeSavage, RA Suhar, N Broguiere, MP Lutolf… - stanford.edu
Organotypic models of patient-specific tumours are revolutionizing our understanding of
cancer heterogeneity and its implications for personalized medicine. These advancements …
cancer heterogeneity and its implications for personalized medicine. These advancements …
Engineered extracellular matrices reveal stiffness-mediated chemoresistance in patient-derived pancreatic cancer organoids
BL LeSavage, AE Gilchrist, BA Krajina, K Karlsson… - 2022 - europepmc.org
Pancreatic ductal adenocarcinoma (PDAC) is characterized by its fibrotic and stiff
extracellular matrix (ECM); however, the role that altered cell-ECM signaling may play in …
extracellular matrix (ECM); however, the role that altered cell-ECM signaling may play in …